Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Arcadia Biosciences, Inc.RKDA · Entity 8593 | Director | August 19, 2024 | August 21, 2024 |
| LIFECORE BIOMEDICAL, INC. \DE\LNDC · Entity 6447 | Director | June 04, 2022 | June 07, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Arcadia Biosciences, Inc.
Report date August 19, 2024 · Filed August 21, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.71 · Expires 2034-08-19 | Direct | 13,255 |
Reported balance
After 2024-08-19 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-08-19 · Grant · Acquired 10,909 · Balance 13,255 F1: The Option will become 100% vested and exercisable on the earlier to occur of (i) August 19, 2025 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service. |
Filing footnotes · ownership attribution and instrument terms
F1: The Option will become 100% vested and exercisable on the earlier to occur of (i) August 19, 2025 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service.
LIFECORE BIOMEDICAL, INC. \DE\
Report date June 04, 2022 · Filed June 07, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 36,588 |
Reported balance
After 2022-06-04 transaction · row 1
1 source rowRow 1 · 2022-06-04 · Grant · Acquired 7,059 · Balance 36,588 F1: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Expires 2022-06-04 | Direct | 0 |
Reported balance
After 2022-06-04 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-06-04 · Exercise / conversion · Disposed 7,059 · Balance 0 F1: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2: The restricted stock units were granted on June 4, 2021. F3: The restricted stock units vested on June 4, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.
F2: The restricted stock units were granted on June 4, 2021.
F3: The restricted stock units vested on June 4, 2022.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 19, 2024 Filed Aug 21, 2024 23:20 UTC | Arcadia Biosciences, Inc. RKDA · Entity 8593 | GrantStock Option (Right to Buy) · Derivative | 10,909 | $0.00 Strike: $2.71 | $0.00 |
DisclosureSEC source: 0000950170-24-099621 · ownership.xml · derivative · entry 1 Carosella Deborah D · CIK 0001701600 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,255 Underlying: Common Stock · 10,909 shares Expires 2034-08-19 F1 · derivative.exercise_date: The Option will become 100% vested and exercisable on the earlier to occur of (i) August 19, 2025 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service. Read SEC document |
| June 06, 2023 Filed Jun 16, 2023 17:19 UTC | Arcadia Biosciences, Inc. RKDA · Entity 8593 | GrantStock Option (Right to Buy) · Derivative | 937 | $0.00 Strike: $4.80 | $0.00 |
DisclosureSEC source: 0001209191-23-037763 · doc4.xml · derivative · entry 1 Carosella Deborah D · CIK 0001701600 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,346 Underlying: Common Stock · 937 shares Expires 2033-06-06 F1 · derivative.exercise_date: The Option will become 100% vested and exercisable on the earlier to occur of (i) June 6, 2024 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service. Read SEC document |
| June 04, 2022 Filed Jun 7, 2022 21:15 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRestricted Stock Unit · Derivative | 7,059 | $9.50 | $67,060.50 |
DisclosureSEC source: 0001628280-22-016483 · wf-form4_165463654263124.xml · derivative · entry 2 Carosella Deborah D · CIK 0001701600 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,059 shares Expires 2022-06-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · shares: The restricted stock units were granted on June 4, 2021. F3 · derivative.exercise_date: The restricted stock units vested on June 4, 2022. F3 · derivative.expiration_date: The restricted stock units vested on June 4, 2022. Read SEC document |
| June 04, 2022 Filed Jun 7, 2022 21:15 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantCommon Stock | 7,059 | $9.50 | $67,060.50 |
DisclosureSEC source: 0001628280-22-016483 · wf-form4_165463654263124.xml · nonDerivative · entry 1 Carosella Deborah D · CIK 0001701600 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,588 F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 16:49 UTC | Arcadia Biosciences, Inc. RKDA · Entity 8593 | GrantStock Option (right to buy) · Derivative | 23,620 | $0.00 Strike: $1.34 | $0.00 |
DisclosureSEC source: 0001209191-22-033860 · doc4.xml · derivative · entry 1 Carosella Deborah D · CIK 0001701600 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,408 Underlying: Common Stock · 23,620 shares Expires 2032-06-01 F1 · derivative.exercise_date: The Option will become 100% vested and exercisable on the earlier to occur of (i) June 1, 2023 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service. Read SEC document |
| May 31, 2022 Filed Jun 2, 2022 16:45 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantRestricted Stock Unit · Derivative | 9,474 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-22-016008 · wf-form4_165418833981827.xml · derivative · entry 1 Carosella Deborah D · CIK 0001701600 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,474 Underlying: Common Stock · 9,474 shares Expires not disclosed F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · derivative.expiration_date: Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock. Read SEC document |
| June 04, 2021 Filed Jun 8, 2021 23:54 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantRestricted Stock Unit · Derivative | 7,059 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001593968-21-001566 · primary_01.xml · derivative · entry 1 Carosella Deborah D · CIK 0001701600 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,059 Underlying: Common Stock · 7,059 shares Expires not disclosed F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · derivative.expiration_date: Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 20:10 UTC | Arcadia Biosciences, Inc. RKDA · Entity 8593 | GrantStock Option (right to buy) · Derivative | 10,935 | $0.00 Strike: $2.89 | $0.00 |
DisclosureSEC source: 0001209191-21-038196 · doc4.xml · derivative · entry 1 Carosella Deborah D · CIK 0001701600 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,788 Underlying: Common Stock · 10,935 shares Expires 2031-06-02 F1 · derivative.exercise_date: The Option will become 100% vested and exercisable on the earlier to occur of (i) June 2, 2022 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service. Read SEC document |
| June 01, 2021 Filed Jun 4, 2021 00:06 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRestricted Stock Unit · Derivative | 8,303 | $11.64 | $96,646.92 |
DisclosureSEC source: 0001593968-21-001523 · primary_01.xml · derivative · entry 2 Carosella Deborah D · CIK 0001701600 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,303 shares Expires 2021-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · shares: The restricted stock units were granted on June 1, 2020. F3 · derivative.exercise_date: The restricted stock units vested on June 1, 2021. F3 · derivative.expiration_date: The restricted stock units vested on June 1, 2021. Read SEC document |
| June 01, 2021 Filed Jun 4, 2021 00:06 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantCommon Stock | 8,303 | $11.64 | $96,646.92 |
DisclosureSEC source: 0001593968-21-001523 · primary_01.xml · nonDerivative · entry 1 Carosella Deborah D · CIK 0001701600 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,529 F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 21:23 UTC | Arcadia Biosciences, Inc. RKDA · Entity 8593 | GrantStock Option (right to buy) · Derivative | 21,853 | $0.00 Strike: $3.25 | $0.00 |
DisclosureSEC source: 0001209191-21-013784 · doc4.xml · derivative · entry 1 Carosella Deborah D · CIK 0001701600 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,853 Underlying: Common Stock · 21,853 shares Expires 2031-02-22 F1 · derivative.exercise_date: The shares subject to the Option shall vest and become exercisable in three (3) equal annual installments, with one-third of the shares subject to the Option vesting on each of the first three (3) anniversaries of the date of the award, subject to the Participant's continued service through each applicable vesting date. Read SEC document |
| October 15, 2020 Filed Oct 19, 2020 20:20 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRestricted Stock Unit · Derivative | 2,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-20-002071 · primary_01.xml · derivative · entry 2 Carosella Deborah D · CIK 0001701600 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,200 shares Expires 2020-10-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · shares: The restricted stock units were granted on October 15, 2019. F3 · derivative.exercise_date: The restricted stock units vested on October 15, 2020. F3 · derivative.expiration_date: The restricted stock units vested on October 15, 2020. Read SEC document |
| October 15, 2020 Filed Oct 19, 2020 20:20 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantCommon Stock | 2,200 | $10.36 | $22,792.00 |
DisclosureSEC source: 0001593968-20-002071 · primary_01.xml · nonDerivative · entry 1 Carosella Deborah D · CIK 0001701600 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,226 F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| June 01, 2020 Filed Jun 2, 2020 22:17 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantRight to Buy Restricted Stock Unit (RSU) · Derivative | 8,303 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-20-008840 · wf-form4_159113624899775.xml · derivative · entry 1 Carosella Deborah D · CIK 0001701600 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,303 Underlying: Common Stock · 8,303 shares Expires not disclosed F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · derivative.expiration_date: Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock. Read SEC document |
| May 28, 2020 Filed May 29, 2020 19:55 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRestricted Stock Unit · Derivative | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-20-008628 · wf-form4_159078208690325.xml · derivative · entry 2 Carosella Deborah D · CIK 0001701600 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires 2020-05-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · shares: The restricted stock units were granted on May 28,2019. F3 · derivative.exercise_date: The restricted stock units vested on May 28, 2020. F3 · derivative.expiration_date: The restricted stock units vested on May 28, 2020. Read SEC document |
| May 28, 2020 Filed May 29, 2020 19:55 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantCommon Stock | 6,000 | $10.99 | $65,940.00 |
DisclosureSEC source: 0001628280-20-008628 · wf-form4_159078208690325.xml · nonDerivative · entry 1 Carosella Deborah D · CIK 0001701600 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,026 F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| October 15, 2019 Filed Oct 17, 2019 19:17 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantRight to Buy Restricted Stock Unit (RSU) · Derivative | 2,200 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-19-012375 · wf-form4_157133983451880.xml · derivative · entry 1 Carosella Deborah D · CIK 0001701600 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,200 Underlying: Common Stock · 2,200 shares Expires not disclosed F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · derivative.expiration_date: Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock. Read SEC document |
| May 30, 2019 Filed May 31, 2019 00:39 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRestricted Stock Unit · Derivative | 4,240 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-19-007413 · wf-form4_155926313128010.xml · derivative · entry 2 Carosella Deborah D · CIK 0001701600 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,240 shares Expires 2019-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · shares: The restricted stock units were granted on May 30,2018. F3 · derivative.exercise_date: The restricted stock units vested on May 30, 2019. F3 · derivative.expiration_date: The restricted stock units vested on May 30, 2019. Read SEC document |
| May 30, 2019 Filed May 31, 2019 00:39 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 4,240 | $9.91 | $42,018.40 |
DisclosureSEC source: 0001628280-19-007413 · wf-form4_155926313128010.xml · nonDerivative · entry 1 Carosella Deborah D · CIK 0001701600 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,526 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| May 28, 2019 Filed May 31, 2019 00:39 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantRight to Buy Restricted Stock Units (RSU) · Derivative | 6,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-19-007413 · wf-form4_155926313128010.xml · derivative · entry 3 Carosella Deborah D · CIK 0001701600 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires not disclosed F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F4 · derivative.expiration_date: Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock. Read SEC document |
| January 08, 2019 Filed Jun 3, 2019 19:52 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | PurchaseCommon Stock | 4,500 | $11.34 | $51,030.00 |
DisclosureSEC source: 0001628280-19-007495 · wf-form4_155959153443136.xml · nonDerivative · entry 1 Carosella Deborah D · CIK 0001701600 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust Disclosed balance after: 13,026 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $11.31 to $11.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| May 30, 2018 Filed Jun 1, 2018 21:36 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRight to Buy Restricted Stock Unit (RSU) · Derivative | 4,240 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-18-011102 · rdgdoc.xml · derivative · entry 1 Carosella Deborah D · CIK 0001701600 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,240 Underlying: Common Stock · 4,240 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · derivative.expiration_date: Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock. Read SEC document |
| May 23, 2018 Filed May 25, 2018 21:40 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRestricted Stock Unit · Derivative | 4,286 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-010775 · rdgdoc.xml · derivative · entry 2 Carosella Deborah D · CIK 0001701600 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,286 shares Expires 2018-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · shares: The restricted stock units were granted on June 1, 2017. F3 · derivative.exercise_date: The restricted stock units vested on May 23, 2018. Read SEC document |
| May 23, 2018 Filed May 25, 2018 21:40 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 4,286 | $13.65 | $58,503.90 |
DisclosureSEC source: 0001437749-18-010775 · rdgdoc.xml · nonDerivative · entry 1 Carosella Deborah D · CIK 0001701600 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,286 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| June 01, 2017 Filed Jun 5, 2017 23:17 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRight to Buy Restricted Stock Unit (RSU) · Derivative | 4,286 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-17-010664 · rdgdoc.xml · derivative · entry 1 Carosella Deborah D · CIK 0001701600 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,286 Underlying: Common Stock · 4,286 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · derivative.expiration_date: Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.